DiscoverMoneycontrol Podcast3269: Coronavirus Essential | Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech; France looking to secure the Indian vaccine
3269: Coronavirus Essential | Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech; France looking to secure the Indian vaccine

3269: Coronavirus Essential | Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech; France looking to secure the Indian vaccine

Update: 2021-03-03
Share

Description

Tune in to the Coronavirus Essential podcast for all the latest updates on the pandemic.
Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

3269: Coronavirus Essential | Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech; France looking to secure the Indian vaccine

3269: Coronavirus Essential | Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech; France looking to secure the Indian vaccine

moneycontrol